Carol L. Delaney

904 total citations
18 papers, 569 citations indexed

About

Carol L. Delaney is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Organic Chemistry. According to data from OpenAlex, Carol L. Delaney has authored 18 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 5 papers in Organic Chemistry. Recurrent topics in Carol L. Delaney's work include Receptor Mechanisms and Signaling (5 papers), Renin-Angiotensin System Studies (5 papers) and Synthesis and Biological Evaluation (5 papers). Carol L. Delaney is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Renin-Angiotensin System Studies (5 papers) and Synthesis and Biological Evaluation (5 papers). Carol L. Delaney collaborates with scholars based in United States, Germany and Taiwan. Carol L. Delaney's co-authors include Suzanne Moreland, John T. Hunt, Ving G. Lee, Diane M. McMullen, Kenneth E.J. Dickinson, Sylvia Yanagisako, J. Eileen Bird, Arthur V. Miller, Robert Cohen and Thomas L. Waldron and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Hypertension and Journal of Medicinal Chemistry.

In The Last Decade

Carol L. Delaney

18 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol L. Delaney United States 11 254 251 175 118 46 18 569
Anne‐Charlotte Le Monnier de Gouville France 8 180 0.7× 95 0.4× 349 2.0× 221 1.9× 44 1.0× 9 642
Kennard A. Grimes United States 12 157 0.6× 113 0.5× 365 2.1× 62 0.5× 28 0.6× 12 456
Israel Posner United States 12 42 0.2× 50 0.2× 281 1.6× 84 0.7× 66 1.4× 35 627
Maria A. Palomo United States 13 213 0.8× 231 0.9× 264 1.5× 112 0.9× 43 0.9× 19 522
Jeffrey Tong Canada 11 64 0.3× 99 0.4× 178 1.0× 25 0.2× 45 1.0× 25 472
Paula Savage United States 12 228 0.9× 168 0.7× 187 1.1× 170 1.4× 18 0.4× 40 528
R S Chang United States 9 41 0.2× 284 1.1× 240 1.4× 88 0.7× 135 2.9× 9 478
Alain Le Bec France 10 175 0.7× 210 0.8× 482 2.8× 102 0.9× 15 0.3× 11 643
Jon G. Church Canada 11 58 0.2× 91 0.4× 325 1.9× 19 0.2× 44 1.0× 25 620
Kwong‐Yui Tang Taiwan 11 224 0.9× 150 0.6× 354 2.0× 5 0.0× 30 0.7× 17 606

Countries citing papers authored by Carol L. Delaney

Since Specialization
Citations

This map shows the geographic impact of Carol L. Delaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol L. Delaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol L. Delaney more than expected).

Fields of papers citing papers by Carol L. Delaney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol L. Delaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol L. Delaney. The network helps show where Carol L. Delaney may publish in the future.

Co-authorship network of co-authors of Carol L. Delaney

This figure shows the co-authorship network connecting the top 25 collaborators of Carol L. Delaney. A scholar is included among the top collaborators of Carol L. Delaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol L. Delaney. Carol L. Delaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Yanagisako, Sylvia, et al.. (2013). Naturalizing Power. 39 indexed citations
2.
Delaney, Carol L.. (2004). Investigating Culture : An Experiential Introduction to Anthropology. Medical Entomology and Zoology. 24 indexed citations
3.
Campese, Vito M., Kenneth C. Lasseter, Carlos M. Ferrario, et al.. (2001). Omapatrilat Versus Lisinopril. Hypertension. 38(6). 1342–1348. 50 indexed citations
4.
Delaney, Carol L., et al.. (2000). LACK OF NATRIURETIC EFFECT OF OMAPATRILAT. Journal of Hypertension. 18. S161–S162. 2 indexed citations
5.
Ding, Philip Yu An, Oliver Yoa‐Pu Hu, Audrey N. Chang, et al.. (1999). Fosinopril: Pharmacokinetics and Pharmacodynamics in Chinese Subjects. The Journal of Clinical Pharmacology. 39(2). 155–160. 6 indexed citations
6.
Uderman, Howard D., John J. Brennan, Carol L. Delaney, et al.. (1999). Fosinopril and Hydrochlorothiazide Combination versus Individual Components: Lack of a Pharmacokinetic Interaction. Annals of Pharmacotherapy. 33(5). 525–530. 2 indexed citations
7.
Chen, Hong, Philip Yu An Ding, Mau‐Song Chang, et al.. (1998). Pharmacokinetics of Fosinopril in Chinese Patients with Mild to Moderate Congestive Heart Failure. Clinical Drug Investigation. 16(5). 377–385. 1 indexed citations
8.
Dickinson, Kenneth E.J., Robert Cohen, Carol L. Delaney, et al.. (1994). BMS‐180560, an insurmountable inhibitor of angiotensin II‐stimulated responses: comparison with losartan and EXP3174. British Journal of Pharmacology. 113(1). 179–189. 32 indexed citations
9.
Lloyd, John, Denis E. Ryono, J. Eileen Bird, et al.. (1994). Quinoline-4-carboxylic acids as angiotensin II receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 4(1). 195–200. 10 indexed citations
10.
Poss, Michael A., Zhengxiang Gu, Denis E. Ryono, et al.. (1994). 1,4-substituted indoles: a potent and selective class of angiostensin II receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 4(1). 145–150. 10 indexed citations
11.
Weller, Harold N., et al.. (1993). Synthesis of N-Alkyl-1,2,4-oxadiazinones as Angiotensin-II (AT1) Receptor Antagonists. Heterocycles. 36(5). 1027–1027. 11 indexed citations
12.
Hunt, John T., Ving G. Lee, Diane M. McMullen, et al.. (1993). Structure-activity studies of endothelin leading to novel peptide ETA antagonists. Bioorganic & Medicinal Chemistry. 1(1). 59–65. 4 indexed citations
13.
Kim, Kyoung Soon, Ligang Qian, J. Eileen Bird, et al.. (1993). Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationships. Journal of Medicinal Chemistry. 36(16). 2335–2342. 51 indexed citations
14.
Kim, Kyoung Soon, Ligang Qian, Carol L. Delaney, et al.. (1993). Synthesis, Biological Properties, and Structure-Activity Relationships of Quinoxaline Angiotensin II Receptor Antagonists. Bioorganic & Medicinal Chemistry Letters. 3(12). 2667–2670. 15 indexed citations
15.
Atwal, Karnail S., Syed Z. Ahmed, J. Eileen Bird, et al.. (1992). Dihydropyrimidine angiotensin II receptor antagonists. Journal of Medicinal Chemistry. 35(25). 4751–4763. 30 indexed citations
16.
Webb, Maria L., Kenneth E.J. Dickinson, Carol L. Delaney, et al.. (1992). The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta. Biochemical and Biophysical Research Communications. 185(3). 887–892. 51 indexed citations
17.
Moreland, Suzanne, Diane M. McMullen, Carol L. Delaney, Ving G. Lee, & John T. Hunt. (1992). Venous smooth muscle contains vasoconstrictor ETB-like receptors. Biochemical and Biophysical Research Communications. 184(1). 100–106. 219 indexed citations
18.
Weller, Harold N., Arthur V. Miller, Robert V. Moquin, et al.. (1992). Benzothiadiazine dioxides: A new class of potent angiotensin-II (AT1) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 2(9). 1115–1120. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne‐Charlotte Le Monnier de Gouville Breakdown of academic impact, for papers by Kennard A. Grimes Breakdown of academic impact, for papers by Israel Posner Breakdown of academic impact, for papers by Maria A. Palomo Breakdown of academic impact, for papers by Jeffrey Tong Breakdown of academic impact, for papers by Paula Savage Breakdown of academic impact, for papers by R S Chang Breakdown of academic impact, for papers by Alain Le Bec Breakdown of academic impact, for papers by Jon G. Church Breakdown of academic impact, for papers by Kwong‐Yui Tang
Rankless by CCL
2026